Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRT vs IFRT after CHOP for Limited-stage Follicular Lymphoma
NCT02449252Phase 3Unknown
- Sponsor
- Wuhan University
- Start
- Oct 2015
- Primary completion
- Oct 2019
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, doxorubicin, vincristine, prednisone in follicular lymphoma (FL), sponsored by Wuhan University. Status: unknown.
02
Drugs
cyclophosphamidedoxorubicinvincristineprednisone
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02449252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449252.